SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-005346
Filing Date
2024-02-07
Accepted
2024-02-07 19:40:20
Documents
2
Period of Report
2024-01-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2195
2 ex-24.htm EX-24 10791
  Complete submission text file 0001493152-24-005346.txt   14517
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5152
FibroBiologics, Inc. (Issuer) CIK: 0001958777 (see all company filings)

IRS No.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 14019 WYNDHAM TERRACE TRAIL HOUSTON TX 77059
Business Address
Cilento Richard C. Jr. (Reporting) CIK: 0002010661 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41934 | Film No.: 24606418